Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy

Stroke

Volumn 43, Issue 2, 2012, Pages 350-355

  Weber, Ralph ^a   Weimar, Christian ^a   Wanke, Isabel ^a   Möller Hartmann, Claudia ^a   Gizewski, Elke R ^a   Blatchford, Jon ^b   Hermansson, Karin ^c   Demchuk, Andrew M ^d   Forsting, Michael ^a   Sacco, Ralph L ^e   Saver, Jeffrey L ^f   Warach, Steven ^g   Diener, Hans Christoph ^a   Diehl, Anke ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b BOEHRINGER INGELHEIM LTD   (United Kingdom)

^c Boehringer Ingelheim AB   (Sweden)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

cerebral infarction; ischemic stroke; magnetic resonance imaging; mortality; silent brain infarction

Indexed keywords

ADULT; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CHILDHOOD MORTALITY; FEMALE; FOLLOW UP; HUMAN; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; SILENT BRAIN INFARCTION; STROKE;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ASPIRIN; BENZIMIDAZOLES; BENZOATES; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DIPYRIDAMOLE; FEMALE; HUMANS; INTRACRANIAL EMBOLISM; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; STROKE; TICLOPIDINE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84856421415     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.631739     Document Type: Article

References (21)

1. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: A systematic review. Lancet Neurol. 2007;6:611-619. (Pubitemid 46921055)
2. Das RR, Seshadri S, Beiser AS, Kelly-Hayes M, Au R, Himali JJ, et al. Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring Study. Stroke. 2008;39:2929-2935.
3. Prabhakaran S, Wright CB, Yoshita M, Delapaz R, Brown T, DeCarli C, et al. Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study. Neurology. 2008;70:425-430.
4. Bernick C, Kuller L, Dulberg C, Longstreth WT Jr, Manolio T, Beauchamp N, et al. Silent MRI infarcts and the risk of future stroke: the Cardiovascular Health Study. Neurology. 2001;57:1222-1229. (Pubitemid 32947380)
5. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34:1126-1129. (Pubitemid 36547501)
6. Boon A, Lodder J, Heuts-van Raak L, Kessels F. Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality. Stroke. 1994;25:2384-2390. (Pubitemid 24359306)
7. Adachi T, Kobayashi S, Yamaguchi S. Frequency and pathogenesis of silent subcortical brain infarction in acute first-ever ischemic stroke. Intern Med. 2002;41:102-108.
8. Oh SH, Kim NK, Kim SH, Kim JK, Kim HS, Kim WC, et al. The prevalence and risk factor analysis of silent brain infarction in patients with first-ever ischemic stroke. J Neurol Sci. 2010;293:97-101.
9. Putaala J, Kurkinen M, Tarvos V, Salonen O, Kaste M, Tatlisumak T. Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke. Neurology. 2009;72:1823-1829.
10. Silent brain infarction in nonrheumatic atrial fibrillation. EAFT Study Group. European Atrial Fibrillation Trial. Neurology. 1996;46:159-165.
11. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238-1251.
12. Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008;359:1225-1237.
13. Diener HC, Sacco R, Yusuf S. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis. 2007;23:368-380. (Pubitemid 46742325)
14. Derdeyn CP, Khosla A, Videen TO, Fritsch SM, Carpenter DL, Grubb RL Jr, et al. Severe hemodynamic impairment and border zone-region infarction. Radiology. 2001;220:195-201. (Pubitemid 32577985)
15. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997;28: 1932-1939. (Pubitemid 27458998)
16. Kang DW, Lattimore SU, Latour LL, Warach S. Silent ischemic lesion recurrence on magnetic resonance imaging predicts subsequent clinical vascular events. Arch Neurol. 2006;63:1730-1733. (Pubitemid 44925081)
17. Liebetrau M, Steen B, Hamann GF, Skoog I. Silent and symptomatic infarcts on cranial computerized tomography in relation to dementia and mortality: A population-based study in 85-year-old subjects. Stroke. 2004; 35:1816-1820. (Pubitemid 38971857)
18. Ong CT, WPC, Sung SF, Wu CS, Hsu YC. Silent infarction in patients with first-ever stroke. Acta Neurol Taiwan. 2007;16:221-225.
19. Potter GM, Marlborough FJ, Wardlaw JM. Wide variation in definition, detection, and description of lacunar lesions on imaging. Stroke. 2011; 42:359-366.
20. Sasaki M, Hirai T, Taoka T, Higano S, Wakabayashi C, Matsusue E, et al. Discriminating between silent cerebral infarction and deep white matter hyperintensity using combinations of three types of magnetic resonance images: A multicenter observer performance study. Neuroradiology. 2008;50:753-758.
21. Gass A, Ay H, Szabo K, Koroshetz WJ. Diffusion-weighted MRI for the 'small stuff': the details of acute cerebral ischaemia. Lancet Neurol. 2004;3:39-45. (Pubitemid 38018926)